Physician associates & the Leng Review

Why this comes up

This is a live, high-profile NHS story about a question medicine cares about deeply: who is competent to make which decision, and does the patient know who they are seeing? It lets interviewers test your grasp of patient safety, professional honesty and how a medical team actually works.

You are not expected to have an insider’s knowledge of NHS workforce policy. You are expected to explain clearly what a physician associate is, understand one crucial distinction (seeing a diagnosed patient versus an undifferentiated one), and weigh the benefits of the role against the genuine concerns — without turning it into an attack on PAs themselves.

What a physician associate actually is

A physician associate (PA) is a healthcare professional who works within a medical team, supervised by a doctor. They take histories, examine patients, help with diagnosis and management, and perform some procedures — but always under a doctor’s oversight. A closely related role is the anaesthesia associate (AA), who supports anaesthetists.

The training route is different from a doctor’s, and that difference is the heart of the debate:

PAs have existed in the UK since the early 2000s, but the NHS Long Term Workforce Plan proposed expanding their numbers sharply. Since December 2024 they have been regulated by the General Medical Council (GMC) — the same body that regulates doctors, which itself became a point of contention.

Why it became controversial

Two worries drove the debate, and both are genuinely about patients, not professional turf:

• Patient safety & “scope creep” — concern that PAs were sometimes working beyond their training, or standing in for doctors rather than supporting them. The widely cited case of Emily Chesterton, who died in 2022 of a pulmonary embolism after being seen twice by a PA she believed was a GP, became central to the debate.
• Transparency — evidence that many patients did not realise they were seeing a PA rather than a doctor, which cuts against informed consent.

Resident doctors and the BMA also raised that expanding PA roles could reduce training opportunities for junior doctors. Supporters countered that PAs add much-needed capacity, provide continuity on busy wards, and free doctors for more complex work.

The Leng Review (July 2025)

The government commissioned an independent review led by Professor Gillian Leng. Reporting in July 2025, it found the evidence on safety and effectiveness was limited and inconclusive, but concluded there was no convincing reason to abolish the role. Instead it recommended reshaping it. The government accepted the findings in full. The headline changes:

• Rename the role to “physician assistant” (and anaesthesia associates to “physician assistant in anaesthesia”) to signal a supportive, complementary member of the team.
• No undifferentiated patients — PAs should not be the first to assess patients with new, undiagnosed symptoms, except within clearly defined national protocols.
• Clear identification — patients must be able to tell who is a doctor and who is a physician assistant (badges, lanyards, titles).
• A named supervising doctor for every PA, with proper support for those supervisors.
• Experience first — at least two years in secondary care before moving into primary care (GP settings).

The key distinction to grasp

If you remember one thing, make it this. The safety of a PA seeing a patient depends enormously on whether the patient has already been diagnosed:

The ethics, through the four pillars

As with most hot topics, the four pillars give your answer instant structure — and this topic maps onto all four unusually neatly.